Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy D Waight

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncoimmunology|July 4, 2012
Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progressionScott I Abrams, Jeremy D Waight
Human Antibodies|January 14, 2017
Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunitiesJeremy D Waight, Randi B Gombos, Nicholas S Wilson
Frontiers in Immunology|July 11, 2022
Emergence of the CD226 Axis in Cancer ImmunotherapyMichael Conner, Ken W Hance, Sapna Yadavilli, et al.
Plos One|November 24, 2011
Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanismJeremy D Waight, Qiang Hu, Austin Miller, et al.
The Journal of Biological Chemistry|April 23, 2014
Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemiaJeremy D Waight, Debarati Banik, Elizabeth A Griffiths, et al.
The Journal of Clinical Investigation|October 5, 2013
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axisJeremy D Waight, Colleen Netherby, Mary L Hensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humansJeremy D Waight, Shinji Takai, Bo Marelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperatureKathleen M Kokolus, Maegan L Capitano, Chen-Ting Lee, et al.
Cancer Cell|June 13, 2018
Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell AntigensJeremy D Waight, Dhan Chand, Sylvia Dietrich, et al.
Molecular Imaging and Biology|October 20, 2022
Immuno-PET Monitoring of CD8<sup>+</sup> T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a <sup>89</sup>Zr Anti-CD8<sup>+</sup> Mouse Minibody in EMT6 Syngeneic Tumor MouseHasan Alsaid, Shih-Hsun Cheng, Meixia Bi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncoimmunology|July 4, 2012
Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progressionScott I Abrams, Jeremy D Waight
Human Antibodies|January 14, 2017
Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunitiesJeremy D Waight, Randi B Gombos, Nicholas S Wilson
Frontiers in Immunology|July 11, 2022
Emergence of the CD226 Axis in Cancer ImmunotherapyMichael Conner, Ken W Hance, Sapna Yadavilli, et al.
Plos One|November 24, 2011
Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanismJeremy D Waight, Qiang Hu, Austin Miller, et al.
The Journal of Biological Chemistry|April 23, 2014
Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemiaJeremy D Waight, Debarati Banik, Elizabeth A Griffiths, et al.
The Journal of Clinical Investigation|October 5, 2013
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axisJeremy D Waight, Colleen Netherby, Mary L Hensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humansJeremy D Waight, Shinji Takai, Bo Marelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperatureKathleen M Kokolus, Maegan L Capitano, Chen-Ting Lee, et al.
Cancer Cell|June 13, 2018
Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell AntigensJeremy D Waight, Dhan Chand, Sylvia Dietrich, et al.
Molecular Imaging and Biology|October 20, 2022
Immuno-PET Monitoring of CD8<sup>+</sup> T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a <sup>89</sup>Zr Anti-CD8<sup>+</sup> Mouse Minibody in EMT6 Syngeneic Tumor MouseHasan Alsaid, Shih-Hsun Cheng, Meixia Bi, et al.
Pageof 2